An Interim Safety Analysis of Combination Stereotactic Ablative Body Radiotherapy (SABR) with Adjuvant Anti-PD1 Immunotherapy in Oligometastatic Renal Cell Carcinoma

被引：0
|
作者：
Siva, Shankar [1 ,2 ,3 ]
Bressel, Mathias [1 ]
Sandhu, Shahneen [1 ]
Tran, Ben [1 ]
Mooi, Jennifer [1 ]
Lewin, Jeremy [1 ]
Loi, Sherene [1 ,2 ,3 ]
Toner, Guy [1 ,2 ,3 ]
Moon, Daniel [1 ]
Goad, Jeremy [1 ]
Shaw, Mark [1 ]
Chander, Sarat [1 ]
Eade, Thomas [4 ]
Guminksi, Alex [4 ]
Dasantha, Jayamanne [4 ]
Pryor, David [5 ]
Cuff, Katherine [5 ]
Wood, Simon [5 ]
Lawrentschuk, Nathan [1 ]
Murphy, Declan [1 ]
机构：
[1] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[2] Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia
[3] Univ Melbourne, Melbourne, Vic, Australia
[4] Northern Sydney Canc Ctr, Sydney, NSW, Australia
[5] Princess Alexandra Hosp, Brisbane, Qld, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
abs19
引用
收藏
页码：31 / 31
页数：1
相关论文
共 50 条
  • [1] Stereotactic body radiotherapy (SBRT)/stereotactic ablative body radiotherapy (SABR) for "radioresistant" renal cell carcinoma (RCC)
    Ishiyama, Hiromichi
    Blanco, Angel I.
    Lo, Simon S.
    Butler, E. Brian
    Teh, Bin S.
    JOURNAL OF RADIATION ONCOLOGY, 2014, 3 (04) : 339 - 346
  • [2] The role of stereotactic ablative body radiotherapy in renal cell carcinoma: focus on oligometastatic and oligoprogressive disease
    Marandino, Laura
    Ciccarese, Chiara
    Francolini, Giulio
    Amparore, Daniele
    Campi, Riccardo
    MINERVA UROLOGY AND NEPHROLOGY, 2023, 75 (02): : 260 - 264
  • [3] Mid -Term Analysis of the Combination Therapy of Axitinib, Toripalimab, and Stereotactic Ablative Body Radiotherapy (SABR) in the Treatment of Recurrent Metastatic Renal Cell Carcinoma
    Hu, K.
    Ma, M. W.
    Gao, X. S.
    Chen, J. Y.
    Li, X. Y.
    Qin, S. B.
    Ren, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E538 - E538
  • [4] TOLERABILITY OF STEREOTACTIC ABLATIVE BODY RADIOTHERAPY (SABR) FOR PRIMARY RENAL CELL CARCINOMA: PRELIMINARY ANALYSIS OF THE FASTRACK CLINICAL TRIAL
    Siva, S.
    Jackson, P.
    Brook, N.
    Grills, R.
    Moon, D.
    Lawrentschuk, N.
    Goad, J.
    Kron, T.
    Gill, S.
    Chander, S.
    Tai, K.
    Shaw, M.
    Pham, D.
    Foroudi, F.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2015, 11 : 26 - 27
  • [5] Stereotactic Body Radiotherapy for the Treatment of Oligometastatic Renal Cell Carcinoma
    Ranck, Mark C.
    Golden, Daniel W.
    Corbin, Kimberly S.
    Hasselle, Michael D.
    Liauw, Stanley L.
    Stadler, Walter M.
    Hahn, Olwen M.
    Weichselbaum, Ralph R.
    Salama, Joseph Kamel
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (06): : 589 - 595
  • [6] Total ablative stereotactic body radiotherapy to primary and oligometastatic renal cell carcinoma in medically inoperable cases: An institutional analysis
    Bisht, Shyam Singh
    Kataria, Tejinder
    Shishak, Sorun
    Gupta, Deepak
    Kaliyaperumal, Venkatesan
    Wadhwa, Jyoti
    Suryavanshi, Manav
    Banerjee, Susovan
    Narang, Kushal
    Goyal, Shina
    Rathi, Deepak
    Mayank, Mayur
    Selvaraj, Rajesh
    Khandelwal, Anubhav
    INDIAN JOURNAL OF UROLOGY, 2023, 39 (04) : 303 - 310
  • [7] The Role of Stereotactic Ablative Body Radiotherapy in Renal Cell Carcinoma
    Ali, Muhammad
    Mooi, Jennifer
    Lawrentschuk, Nathan
    Mckay, Rana R.
    Hannan, Raquibul
    Lo, Simon S.
    Hall, William A.
    Siva, Shankar
    EUROPEAN UROLOGY, 2022, 82 (06) : 613 - 622
  • [8] Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies
    Zaorsky, Nicholas G.
    Lehrer, Eric J.
    Kothari, Gargi
    Louie, Alexander, V
    Siva, Shankar
    EUROPEAN UROLOGY ONCOLOGY, 2019, 2 (05): : 515 - 523
  • [9] A Prospective Study of Stereotactic Body Radiotherapy in Oligometastatic Renal Cell Carcinoma
    Katipally, R. R.
    Rajeev-Kumar, G.
    Solanki, A. A.
    Arif, F.
    Eggener, S. E.
    Szmulewitz, R. Z.
    Stadler, W. M.
    Sweis, R. F.
    Pitroda, S. P.
    Liauw, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E545 - E545
  • [10] Synergistic effect of anti-PD1 immunotherapy then radiotherapy in advanced basal cell carcinoma
    Malmontet, T.
    Dousset, L.
    Gerard, E.
    Ouhabrache, N.
    Pham-Ledard, A.
    Beylot-Barry, M.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2020, 147 (03): : 228 - 232
12345